The Community invests more than 36 million euros in vaccines for adults and children.
for the calendars of childhood immunizations and the adult.
-the Governing Council authorized the acquisition of more than 1.3 million doses in 14 batches, for 2012
-Vaccines will be supplied to about 660 centres authorized public and private health network
Madrid, November of 2011- the Council of Government today approved the procedure for the acquisition of vaccines for the campaign for children and adults, within their respective calendars of 2012, for an amount of 36.674.833 euros.
The vaccines will be supplied to about 660 vaccination centres belonging to the authorized public and private health network.
They will acquire in total 1.370.100 doses of vaccines in 14 batches. Lots correspond to different types and forms of vaccines, including injectable polio, hepatitis b child, HB hemodializados, difteria-t̩tanos Рwhooping cough, triple viral (measles, rubella, mumps), chickenpox, and Pneumococcus.
Immunization is a preventive intervention performed on susceptible to disease, healthy population using vaccines developed with the most modern technologies and that have amply demonstrated its safety and efficacy. It is the best measure of prevention and protection in the most appropriate age.
The children’s immunization schedule begins with the birth of the child and the administration of the vaccine against hepatitis B, and ends at age 14 with diptheria and papillomavirus vaccines. The community of Madrid was the first to include in its calendar infant pneumococcal vaccine.
Adults calendar has a set of guidelines to be followed depending on the age of the person. In general terms, all adults with incomplete vaccination or not vaccinated in childhood should be completed its vaccination scheme.
In the community of Madrid, routine immunization programmes have always had a very important follow-up, as a result of the confidence that both the population and health professionals have in vaccines. This situation has led to achieve vaccine coverage very high, especially important in the early years of life. The result has been the control and elimination of communicable diseases front that is available of a vaccine effective
